Prostate cancer treatment best based on life-expectancy
This article was originally published in Clinica
Executive Summary
Prostate cancer patients with "long life-expectancies who are not a great surgical risk and who have a preference to undergo surgery" are most likely to benefit from radical prostatectomy. Those with "long life expectancy, no risk factors for the treatment, and a preference for radiation therapy" will most likely benefit from this type of treatment, while patients with shorter life-expectancy and/or low grade tumours may benefit most from surveillance. These are the conclusions of the Prostate Cancer Clinical Guidelines Panel of the American Urological Association (Journal of Urology, Vol. 154, pp. 2144-2148).